Live Feed
Delayed 3mPress · Analyst · Insider · Buys · FDA
Signed out · 3-min delay · Sign up for real-time
- Officer Clark Kyle sold $712,935 worth of shares (45,000 units at $15.84) as part of a pre-agreed trading plan (SEC Form 4)
4 - BETA Technologies, Inc. (0001784570) (Issuer)
- SEC Form 4 filed by Executive VP Clark Moore
4 - PEDEVCO CORP (0001141197) (Issuer)
- i-80 Gold Announces Voting Results from Its 2026 Annual Meeting of Shareholders
TORONTO, June 23, 2026 /CNW/ - i-80 GOLD CORP. (NYSE:IAUX) (TSX:IAU) ("i-80" or the "Company") is pleased to announce the results of its 2026 annual meeting of shareholders (the "Meeting") held on June 23, 2026. A total of 509,632,021 common shares, representing approximately 60% of the Company's outstanding common shares as at the April 27, 2026 record date, were represented at the Meeting. A summary of the results are as follows: 1. Number of Directors At the Meeting, shareholders approved setting the number of directors of the Company at nine.2. Election of Directors All di
- SEC Form 4 filed by Chief Executive Officer Hardwick Mark K
4 - FIRST MERCHANTS CORP (0000712534) (Issuer)
- SEC Form 4 filed by Director Harmon Cyrus
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- Orla Mining Announces Receipt of Interim Order and Filing and Mailing of Meeting Materials for Special Meeting of Shareholders to Approve the Arrangement with Equinox Gold Corp.
Your vote matters to your investment – vote today!The Board of Directors of Orla unanimously recommends that Shareholders vote FOR the Arrangement Resolution.Shareholder questions or need voting assistance? Please contact Laurel Hill Advisory Group by email at assistance@laurelhill.com, or by texting "INFO" to, or calling, 1-877-452-7184 (North American toll-free) or 1-416-304-0211 (outside North America).VANCOUVER, BC, June 23, 2026 /CNW/ - Orla Mining Ltd. (TSX:OLA) (NYSE:ORLA) ("Orla" or the "Company") is pleased to announce that in connection with the previously announced business combination (the "Arrangement") with Equinox Gold Corp. (TSX:EQX, NYSE:EQX) ("Equinox"), Orla has filed and
- Equinox Gold Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders to Approve Business Combination with Orla Mining
VANCOUVER, British Columbia, June 23, 2026 (GLOBE NEWSWIRE) -- Equinox Gold Corp. (TSX:EQX, NYSE:EQX) ("Equinox Gold" or the "Company") will hold a special meeting of shareholders ("Meeting") on July 22, 2026 commencing at 9:00 am Vancouver time. Your vote is important, regardless of how many shares you own.The board of directors of both companies unanimously recommend a vote FOR the Arrangement.Shareholders with questions or requiring assistance in voting are asked to contact Laurel Hill Advisory Group by calling 1-877-452-7184 (North America toll-free) or 1-416-304-0211 (international), by texting "INFO" to either 1-877-452-7184 or 1-416-304-0211, or by email at assistance@laurelhill.co
- Algoma Steel Group Inc. Announces Results of Voting at Annual Meeting of Shareholders
SAULT STE. MARIE, Ontario, June 23, 2026 (GLOBE NEWSWIRE) -- Algoma Steel Group Inc. (NASDAQ:ASTL, TSX:ASTL) ("Algoma" or "the Company"), a leading Canadian producer of steel plate and hot rolled sheet products, announced today the results of voting at its annual meeting of shareholders (the "Meeting") held on June 23, 2026. All of the nominees listed in the management information circular prepared in connection with the Meeting were elected as directors of the Company. The Company received proxies and virtual votes at the Meeting as set out below: NomineeVotes ForVotes WithheldTotal VotesMary Anne Bueschkens58,484,3401,366,70059,851,040Sean Donnelly59,757,89493,14659,851,040James Gouin59
- Director Tariq Musa sold $255,893 worth of shares (1,951 units at $131.16), decreasing direct ownership by 15% to 11,048 units (SEC Form 4)
4 - Guardant Health, Inc. (0001576280) (Issuer)
- SEC Form 4 filed by Director Butitta Cynthia M
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- Director Potter Myrtle S sold $204,085 worth of shares (1,556 units at $131.16), decreasing direct ownership by 7% to 20,971 units (SEC Form 4)
4 - Guardant Health, Inc. (0001576280) (Issuer)
- SEC Form 4 filed by Director Garland J. Scott
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- Director Mignone Roberto converted options into 528 shares, increasing direct ownership by 6% to 9,482 units (SEC Form 4)
4 - Guardant Health, Inc. (0001576280) (Issuer)
- Cboe Introduces Cboe Predicts, Launching First Products in New Prediction Markets Suite
CHICAGO, June 23, 2026 /PRNewswire/ -- Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity and index derivatives, today announced the launch of the first products in its new prediction markets suite, Cboe PredictsSM. The offering includes binary option contracts based on the Mini-S&P 500 Index (XSP), listed under the symbols XSPBW and XSPBX. The contracts are now available on Interactive Brokers and expected to roll out at Charles Schwab in the coming months, with additional retail brokerage platforms expected to offer access over time
- SEC Form 4 filed by Director Hrustanovic Gorjan
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- SEC Form 4 filed by Director Clark Ian T
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- SEC Form 4 filed by Director Larson Yi
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- Director Ballal Rahul D. converted options into 2,816 shares, increasing direct ownership by 23% to 15,230 units (SEC Form 4)
4 - AGIOS PHARMACEUTICALS, INC. (0001439222) (Issuer)